Your browser doesn't support javascript.
loading
LAD1 expression is associated with the metastatic potential of colorectal cancer cells.
Moon, Byul; Yang, Suk-Jin; Park, Seong Min; Lee, Sang-Hyun; Song, Kyu Sang; Jeong, Eun-Jeong; Park, Mijin; Kim, Jang-Seong; Yeom, Young Il; Kim, Jung-Ae.
  • Moon B; Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South Korea.
  • Yang SJ; Department of Functional Genomics, KRIBB School of Bioscience, University of Science and Technology, Daejeon, 34113, South Korea.
  • Park SM; Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South Korea.
  • Lee SH; Present address: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Song KS; Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South Korea.
  • Jeong EJ; Present address: Translational Research Branch, Research Institute, National Cancer Center, Goyang, 10408, South Korea.
  • Park M; Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South Korea.
  • Kim JS; Department of Pathology, Chungnam National University College of Medicine, Daejeon, 34134, South Korea.
  • Yeom YI; Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, South Korea.
  • Kim JA; Department of Biological Science, College of Natural Sciences, Wonkwang University, Iksan, 54538, South Korea.
BMC Cancer ; 20(1): 1180, 2020 Dec 02.
Article en En | MEDLINE | ID: mdl-33267790
ABSTRACT

BACKGROUND:

Anchoring filament protein ladinin-1 (LAD1) was related to the aggressive progression of breast, lung, laryngeal and thyroid cancers. However, the association of LAD1 with colorectal cancer remained unknown. Here, to determine the relationship of LAD1 with colorectal cancer progression, we explored the effect of LAD1 loss on the malignant features of colorectal cancer cells.

METHODS:

We constructed LAD1-depleted cell lines and examined the effect of LAD1 deficiency on the phenotypic and molecular features of colorectal cancer cells in vitro. The function of LAD1 in metastasis in vivo was examined by establishing a spleen-to-liver metastasis mouse model. LAD1 protein expression in colorectal cancer patient specimens was assessed by immunohistochemistry of tumor microarrays.

RESULTS:

We found that LAD1 was abundant in most colorectal cancer cells. In addition, high expression of LAD1 significantly correlated with poor patient outcome. LAD1 depletion inhibited the migration and invasion of two different colorectal cancer cell lines, SW620 and Caco-2, without affecting their proliferation. In addition, LAD1 loss led to defects in liver metastasis of SW620 cells in the mouse model. Immunohistochemistry of colorectal cancer tissues revealed LAD1 enrichment in metastatic tissues compared to that in primary tumor and normal tissues.

CONCLUSION:

These results suggest that LAD1 expression is associated with the metastatic progression of colorectal cancer by promoting the migration and invasion of cancer cells.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoantígenos / Neoplasias Colorrectales / Colágenos no Fibrilares Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoantígenos / Neoplasias Colorrectales / Colágenos no Fibrilares Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article